{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:24:11Z","timestamp":1787649851382,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Copeptin, a stable surrogate marker of arginine vasopressin, reflects neurohumoral activation and hemodynamic stress. Its prognostic value in heart failure is established, but its role in atrial fibrillation (AF) recurrence and mortality remains unclear. This study aimed to compare copeptin concentrations in patients with AF and controls, evaluate biochemical and echocardiographic associations, and assess copeptin associations with 12-month AF recurrence and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective observational study included 100 hospitalized patients with AF and 50 controls in sinus rhythm. Participants underwent clinical evaluation, echocardiography, biochemical testing, and measurement of copeptin, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high-sensitivity cardiac troponin T (hsTnT). AF recurrence was evaluated in 62 patients after sinus-rhythm restoration; mortality was assessed in all 100 patients over a 12-month follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median copeptin concentration was higher in patients with AF than in controls, 14.52 (6.98\u201336.83) versus 4.10 (2.70\u20136.88) pmol\/L (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001), and remained higher after adjustment for age and sex (adjusted geometric mean ratio, 2.995; 95% CI, 2.040\u20134.398;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001). In patients with AF, copeptin correlated positively with C-reactive protein (\u03c1\u2009=\u20090.4862), hsTnT (\u03c1\u2009=\u20090.4904), NT-proBNP (\u03c1\u2009=\u20090.3458), left atrial volume index (LAVi; \u03c1\u2009=\u20090.2598), and left ventricular mass index (\u03c1\u2009=\u20090.2252), and inversely with estimated glomerular filtration rate (\u03c1\u2009=\u2009\u22120.3231) and tricuspid annular plane systolic excursion (\u03c1\u2009=\u2009\u22120.2277; all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Each 10-pmol\/L copeptin increase was independently associated with 61% higher AF recurrence odds after adjustment for age, LAVi, and left ventricular ejection fraction (adjusted OR, 1.61; 95% CI, 1.01\u20132.56). Copeptin showed modest discrimination for AF recurrence (AUC, 0.674; 95% CI, 0.526\u20130.821); the 11.68-pmol\/L cut-off yielded 63.33% sensitivity and 75.00% specificity. Median copeptin concentration was higher in non-survivors than survivors, 35.35 (10.35\u201356.82) versus 12.20 (6.54\u201329.43) pmol\/L (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0051).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In hospitalized patients with AF, copeptin is elevated and associated with cardiac biomarkers, inflammation, and structural and functional echocardiographic abnormalities. Higher copeptin independently predicts AF recurrence after sinus-rhythm restoration and is associated with 12-month all-cause mortality, supporting its potential for risk stratification and prognostic assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1859765","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:10:21Z","timestamp":1787649021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum copeptin predicts atrial fibrillation recurrence and is associated with increased all-cause mortality"],"prefix":"10.3389","volume":"13","author":[{"given":"Martin","family":"Ihnatko","sequence":"first","affiliation":[{"name":"1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice","place":["Ko\u0161ice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Laz\u00farov\u00e1","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Faculty of Medicine, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice","place":["Ko\u0161ice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Jochmanov\u00e1","sequence":"additional","affiliation":[{"name":"1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice","place":["Ko\u0161ice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u013dudmila","family":"Ihnatkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncohematology, Faculty of Medicine, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice","place":["Ko\u0161ice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Laz\u00farov\u00e1","sequence":"additional","affiliation":[{"name":"1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice","place":["Ko\u0161ice, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.19102\/icrm.2023.14025","article-title":"The role of Major biomarkers of stress in atrial fibrillation: a literature review","volume":"14","author":"Rafaqat","year":"2023","journal-title":"J Innov Card Rhythm Manag"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.3390\/ijms26073218","article-title":"Cardiovascular biomarkers: tools for precision diagnosis and prognosis","volume":"26","author":"Netala","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.6515\/ACS.202107_37(4).20210111A","article-title":"Higher copeptin levels are associated with the risk of atrial fibrillation in patients with rheumatic mitral stenosis","volume":"37","author":"Avci","year":"2021","journal-title":"Acta Cardiol Sin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0004563220975171","article-title":"Multiple biomarkers measurement to estimate the duration of atrial fibrillation","volume":"58","author":"Arbault-Biton","year":"2021","journal-title":"Ann Clin Biochem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/jalm\/jfaf153","article-title":"Copeptin as a marker for vasopressin dysregulation and diagnosis","volume":"11","author":"Khattri Bhandari","year":"2026","journal-title":"J Appl Lab Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/biomedicines13092048","article-title":"Copeptin, routine laboratory parameters, and ischemic etiology of heart failure predict outcomes in elderly patients with decompensated heart failure","volume":"13","author":"Nadziakiewicz","year":"2025","journal-title":"Biomedicines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/medicina60111841","article-title":"Predictive value of NT-proBNP, FGF21, galectin-3 and copeptin in advanced heart failure in patients with preserved and mildly reduced ejection fraction and type 2 diabetes Mellitus","volume":"60","author":"Ianos","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/1354750X.2022.2123042","article-title":"Role of copeptin in diagnosis and outcome prediction in patients with heart failure: a systematic review and meta-analysis","volume":"27","author":"Zimodro","year":"2022","journal-title":"Biomarkers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s13312-024-3330-x","article-title":"Plasma copeptin as a prognostic marker in children with heart failure","volume":"61","author":"Abdelaziz","year":"2024","journal-title":"Indian Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1002\/ehf2.13439","article-title":"Copeptin as a predictive marker of incident heart failure","volume":"8","author":"Schill","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1093\/eurheartj\/ehae611","article-title":"Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study","volume":"45","author":"Fabritz","year":"2024","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/STROKEAHA.124.049249","article-title":"Role of NT-proBNP for atrial fibrillation detection after ischemic stroke: a time-dependent relationship","volume":"56","author":"Hatab","year":"2025","journal-title":"Stroke"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2463563","DOI":"10.1080\/0886022X.2025.2463563","article-title":"Brain natriuretic peptide is a biomarker of atrial fibrillation in hemodialysis patients","volume":"47","author":"Yu","year":"2025","journal-title":"Ren Fail"},{"key":"B14","doi-asserted-by":"publisher","first-page":"P4063","DOI":"10.1093\/eurheartj\/eht309.P4063","article-title":"Copeptin levels are associated with cardiovascular events in patients with non valvular atrial fibrillation","volume":"34","author":"Lang","year":"2013","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3760\/cma.j.issn.2095-4352.2018.011.003","article-title":"Diagnostic value of copeptin and cancer antigen 125 in acute heart failure patients with atrial fibrillation and their correlations with short-term cardiovascular events","volume":"30","author":"Ding","year":"2018","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/pace.14399","article-title":"Circulating biomarkers, echocardiographic parameters, and incident subclinical atrial fibrillation in patients with diabetes and hypertension","volume":"45","author":"Philippsen","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"104643","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104643","article-title":"Predictive markers of atrial fibrillation in patients with transient ischemic attack","volume":"29","author":"Pedersen","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.rceng.2023.02.002","article-title":"Is the use of the new Chronic Kidney Disease Epidemiology Consortium (CKD-EPI 2021) formula appropriate for the Spanish population?","volume":"223","author":"Escribano-Serrano","year":"2023","journal-title":"Rev Clin Esp"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.hjc.2018.03.006","article-title":"Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction","volume":"60","author":"Cavusoglu","year":"2019","journal-title":"Hellenic J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccep.2020.10.006","article-title":"Biomarkers in atrial fibrillation: pathogenesis and clinical implications","volume":"13","author":"Noubiap","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"B23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.hjc.2019.10.001","article-title":"Arginine vasopressin and difficult triangle of heart failure, atrial fibrillation, and hyponatremia","volume":"61","author":"Kaya","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/10408363.2024.2383899","article-title":"Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications","volume":"62","author":"Choy","year":"2025","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"115181","DOI":"10.1016\/j.ab.2023.115181","article-title":"Copeptin: up-to-date diagnostic and prognostic role highlight","volume":"673","author":"Abdelmageed","year":"2023","journal-title":"Anal Biochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"963103","DOI":"10.3389\/fcvm.2022.963103","article-title":"Dysnatremia is associated with increased risk of all-cause mortality within 365 days post-discharge in patients with atrial fibrillation without heart failure","volume":"9","author":"Zhou","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/jcm12041482","article-title":"Hyponatremia associated with congestive heart failure: involvement of vasopressin and efficacy of vasopressin receptor antagonists","volume":"12","author":"Ishikawa","year":"2023","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.36660\/abc.20210139","article-title":"Role of sodium levels on atrial fibrillation in heart failure: active player or a bystander?","volume":"118","author":"Aky\u00fcz","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4158\/EP161240.OR","article-title":"Hypernatremia and copeptin levels in the elderly hospitalized patient","volume":"22","author":"Liber","year":"2016","journal-title":"Endocr Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/CIRCHEARTFAILURE.110.960096","article-title":"Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the BACH study","volume":"4","author":"Maisel","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B31","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.3949\/ccjm.73.Suppl_3.S19","article-title":"The role of vasopressin in congestive heart failure","volume":"73","author":"Goldsmith","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1210\/jc.2010-2499","article-title":"Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states","volume":"96","author":"Balanescu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2017.11.040","article-title":"Cardiac troponin and adverse outcomes in atrial fibrillation: a meta-analysis","volume":"477","author":"Fan","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/0004563221989364","article-title":"Copeptin reliably reflects longitudinal right ventricular function","volume":"58","author":"Harbr\u00fccker","year":"2021","journal-title":"Ann Clin Biochem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2796.2010.02287.x","article-title":"Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-AF trial","volume":"269","author":"Latini","year":"2011","journal-title":"J Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e112486","DOI":"10.1371\/journal.pone.0112486","article-title":"Multiple biomarkers and atrial fibrillation in the general population","volume":"9","author":"Schnabel","year":"2014","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e003557","DOI":"10.1161\/jaha.116.003557","article-title":"Short-Term influence of radiofrequency ablation on NT-proBNP, MR-proANP, copeptin, and MR-proADM in patients with atrial fibrillation: data from the observational SMURF study","volume":"5","author":"Charitakis","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1515\/cclm-2016-0151","article-title":"Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study","volume":"54","author":"Odermatt","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ndt\/gfaa308","article-title":"Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes","volume":"37","author":"Heinrich","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"170437","DOI":"10.1016\/j.peptides.2020.170437","article-title":"Vasopressin and copeptin release during sepsis and septic shock","volume":"136","author":"Gomes","year":"2021","journal-title":"Peptides"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1859765\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:10:25Z","timestamp":1787649025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1859765\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":40,"alternative-id":["10.3389\/fcvm.2026.1859765"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1859765","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1859765"}}